Ireland
--:--IST
Enrolling by invitation Not applicable

Engaging Home-monitored Assessment to Navigate Clinical Decision-making

NCT07399912 · tracked via the Priya Life Science Singapore tracker
Phase
Not applicable
Started
2025-10-01
Last updated
2026-02-10

Condition(s) studied

Hypertension,Essential

Investigational drug(s) / intervention(s)

ENHANCe appTeaching and trainingUsual care

ENHANCe app: ENHANCe app is a prototype; it is a smartphone based clinical decision support (CDS) tool to manage patients with hypertension using their home blood pressure. The app will scan patients' home BP records from paper or mobile phone, and provide a recommendation to the doctor on how to manage their blood pressure. The patient will not need to use the device during the study period. However, the recommendation from the ENHANCe app will be available to the doctor to manage your blood pressure during the study period if the patient is in the intervention group.

Teaching and training: All patients will have access to online educational resources throughout the study. After recruitment, they will receive a nurse-led education on HBP monitoring. The research team will train all primary care physicians (PCPs) on managing patients with hypertension using HBP records.

Usual care: Physicians manage patients using HBP records at their discretion

Study summary

This study is testing a new app called ENHANCe, which is designed to help family doctors manage patients with high blood pressure using readings taken at home.

Eligibility

Sex
ALL
Min age
21 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: For primary care physicians: * PCPs aged 21 years and above. * Involved in the clinical management of patients with hypertension in the past six months. For patients: * Patients aged 21 years and above * Documentation of hypertension diagnosis in EMR * Owns an HBP monitoring device Exclusion Criteria for patients: * Documentation of dementia diagnosis in EMR * Audio or visual impairments * Hypertensive urgency or emergency

Primary outcome measure(s)

  • Response rate of participants — 6 months
    Participants agreeable to participate in the study
  • Agreement with the CDSS recommendation among PCPs — 6 months
    Proportion of PCPs who agree with the CDSS recommendation in the two groups
  • Withdrawal rate — 6 months
    Proportion of participants who withdrew
  • Study completion rate — 6 months
    Proportion of participants who completed the intervention
  • Adverse event rates — 6 months
    Proportion of adverse events reported in the two groups
  • Consult duration — 6 months
    Consult time in the groups
  • Ease of home blood pressure record assessment among PCPS — 6 months
    Ease of home blood pressure record assessment among PCPS in the two arms

Trial sites (1)

FacilityCityRegionStatus
SingHealth Polyclinics Singapore Singapore
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07399912 on ClinicalTrials.gov ↗ ← All trials in Singapore